Patent ID: 9617341
Date: 2017-04-11
CPC Classifications: A61K,A61P,C07K,C12N,C12P

Claim:
1. A method for blocking or reducing binding of IL-6 to IL-6R, said method comprising administering, to a human subject, a pharmaceutically active amount of at least one polypeptide that can specifically bind to IL-6R and that blocks or reduces the interaction between IL-6 and IL-6R, wherein the polypeptide essentially consists of 4 framework regions (FR1 to FR4 respectively) and 3 complementarity determining regions (CDR1 to CDR3), in which: CDR1 is chosen from the group consisting of: and CDR2 is chosen from the group consisting of: and CDR3 is chosen from the group consisting of: